Verapamil in acute myocardial infarction. The Danish Multicentre Study Group.
The reasons for starting a trial of verapamil in early intervention of acute myocardial infarction (AMI) are reviewed. In a pilot study of sixty-one patients it was demonstrated that verapamil probably had no harmful effects in patients with AMI. A multicentre study is now in progress in Denmark; 1433 have been included. Patients are treated with either placebo or verapamil 120 mg three times a day for 6 months. The results of the study, that is effect of verapamil treatment on death and reinfarction, will be available in 1982.
D002121:Calcium Channel Blockers / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003325:Coronary Care Units; D003329:Coronary Vasospasm / Q000188:drug therapy; D003718:Denmark; D006801:Humans; D009203:Myocardial Infarction / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology; D013997:Time Factors; D014700:Verapamil / Q000627:therapeutic use*
D002121:Calcium Channel Blockers; D014700:Verapamil